维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="GLUZ O"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Biological characteristics in triple negative high risk breast cancer and their clincal implications 显示文摘	Herr A Gluz O Ting E	2006	Proc Am Soc Clin Oncal2006，24，20：	1
2	Triple-negative highrisk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy:results of WSG AM01 trial显示文摘	Gluz O Nitz UA Harbeck N	2008	Ann Oncol2008，19，5：	1
3	Triple-negative highrisk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial显示文摘	Gluz O Nitz UA Harbeck N	2008	Ann Oncol2008，19，5：	1
4	Retrospective analysis of WSG AM01 tandem high dose chemotherapy trail in high risk primary breast cancer: A hypothesis generating study显示文摘	NITZ UA GLUZ O HERR A	2006	Clin Oncol2006，24，18：	1
5	Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose~dense chemotherapy显示文摘	Raihanatou D Ting E Gluz O	2007	Clin Cancer Res2007，13，：	1
6	Triple-negative breastcancercurrent status and future directions显示文摘	Gluz O Liedtke C Gottschalk N	2009	Ann Oncol2009，20，12：	1
7	Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy;results of WSG AM-01 trial显示文摘	Gluz O Nitz UA Harbeck N	2008	Ann Oncol2008，19，5：	1
8	Triple - negative breast cancer - current status and future directions 显示文摘	Gluz O Liedtke C Gottschalk N	2009	Ann Oncol2009，20，12：	1
9	Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy显示文摘	DIALLO-DANEBROCK R TING E GLUZ O	2007	Clin Cancer Res2007，13，21：	1
10	The prognostic impact of age in different molecular subtypes of breast cancer显示文摘	Liedtke C Rody A Gluz O	2015	Breast Cancer Res Treat2015，152，3：	1
11	Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy 显示文摘	DIALLO-DANEBROCK R TING E GLUZ O	2007	Clin Cancer Res2007，13，21：	1
12	Triple - negative breast cancer- current status and future directions 显示文摘	Gluz O Liedtke C Gottschalk N	2009	Ann 0ncol2009，20，12：	1
13	Triple-negative breast cancer-current status and future directions 显示文摘	Gluz O Liedtke C Gottschalk N	2009	Ann Oncol2009，20，12：	1
14	Triple-negative high- risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial显示文摘	Gluz O Nitz UA Harbeck N	2008	Ann Oncol2008，19，5：	1
15	Triple-negative breast cancerdcurrent status and future directions显示文摘	Gluz O Liedtke C Gottschalk N	2009	Ann Oncol2009，20，12：	1
16	Triple-negative breast cancer- current status and future directions 显示文摘	Gluz O Liedtke C Gottschalk N	2009	Ann Oncol2009，20，12：	1
17	Biological characteristics in triple negative high risk breast cancer and their clinical implications显示文摘	Herr A Gluz O Ting E	2006	Proc Am Soc Clin Oncol2006，24，：	1
18	Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy 显示文摘	Danebrock RD Ting E Gluz O	2007	Clin Cancer Res2007，13，2：	1
19	The prognostic impact of age in different molecular subtypes of breast cancer 显示文摘	Liedtke C Rody A Gluz O	2015	Breast Cancer Res Treat2015，152，3：	1
20	Triple- negative high -risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM -01 trial显示文摘	Gluz O Nitz U A Harbeck N	2008	Ann Oncol2008，19，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示